MedTrace Logo

Vitamin D Supplementation on Cardiovascular Risk Factors

NCT01412710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2017-12-12

Study results available
· View outcomes & findings →

Summary

The purpose of the present pilot study is to determine the effect of vitamin D supplementation (4000 IU or 6000 IU once daily for 6 months) on reducing heart disease risk and in improving blood glucose control in type 2 Diabetes subjects . The investigators are working with Hispanics and African Americans living in Miami, Florida.

Conditions

Interventions

DRUG

Cholecalciferol

4000 IU or 6000 IU given vitamin D3 once daily, orally for 6 months.

Sponsors & Collaborators

  • Florida International University

    lead OTHER

Principal Investigators

  • Fatma G Huffman, PhD · Florida International University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01412710 on ClinicalTrials.gov